Michelle Weese's most recent trade in Krispy Kreme Inc was a trade of 6,672 Common Stock done . Disclosure was reported to the exchange on April 11, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Krispy Kreme Inc | Michelle Weese | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Apr 2024 | 6,672 | 25,809 | - | 0 | Common Stock | |
| Bristol-Myers Squibb Co. | Michelle Weese | EVP, Corporate Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2023 | 1,885 | 3,770 | - | - | Restricted Stock Units | |
| Bristol-Myers Squibb Co. | Michelle Weese | EVP, Corporate Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2023 | 1,885 | 4,135 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Bristol-Myers Squibb Co. | Michelle Weese | EVP, Corporate Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.95 per share. | 01 Jul 2023 | 682 | 3,453 (0%) | 0% | 64.0 | 43,614 | Common Stock, $0.10 par value |
| Krispy Kreme Inc | Michelle Weese | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2023 | 6,579 | 19,137 | - | 0 | Common Stock | |
| Bristol-Myers Squibb Co. | Michelle Weese | EVP, Corporate Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 9,660 | 9,660 | - | - | Performance Shares | |
| Bristol-Myers Squibb Co. | Michelle Weese | EVP, Corporate Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 6,440 | 6,440 | - | - | Market Share Units | |
| Bristol-Myers Squibb Co. | Michelle Weese | EVP, Corporate Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2023 | 1,590 | 2,793 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Bristol-Myers Squibb Co. | Michelle Weese | EVP, Corporate Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2023 | 1,590 | 4,773 | - | - | Market Share Units | |
| Bristol-Myers Squibb Co. | Michelle Weese | EVP, Corporate Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.71 per share. | 10 Mar 2023 | 594 | 2,250 (0%) | 0% | 65.7 | 39,032 | Common Stock, $0.10 par value |
| Bristol-Myers Squibb Co. | Michelle Weese | EVP, Corporate Affairs | Other type of transaction at price $ 0.00 per share. | 10 Mar 2023 | 51 | 2,844 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Bristol-Myers Squibb Co. | Michelle Weese | EVP, Corporate Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2022 | 1,885 | 5,655 | - | - | Restricted Stock Units | |
| Bristol-Myers Squibb Co. | Michelle Weese | EVP, Corporate Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2022 | 1,885 | 1,885 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Bristol-Myers Squibb Co. | Michelle Weese | EVP, Corporate Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 76.84 per share. | 01 Jul 2022 | 682 | 1,203 (0%) | 0% | 76.8 | 52,405 | Common Stock, $0.10 par value |
| Krispy Kreme Inc | Michelle Weese | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2022 | 6,901 | 12,558 | - | 0 | Common Stock | |
| Bristol-Myers Squibb Co. | Michelle Weese | EVP, Corporate Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 9,544 | 9,544 | - | - | Performance Shares | |
| Bristol-Myers Squibb Co. | Michelle Weese | EVP, Corporate Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 6,363 | 6,363 | - | - | Market Share Units | |
| Bristol-Myers Squibb Co. | Michelle Weese | EVP, Corporate Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 7,540 | 7,540 | - | - | Restricted Stock Units |